According to AlphaMoat, in October 2026 Insilico Medicine (insilico.com) received 47,472 monthly visits (-26.7% MoM) — ranked #5,049 of 17,609 AI websites with traffic data, and #603 of 3,112 in Industry Services; its largest market is United States (47.1% of visits).
Headquartered in Shanghai, Insilico Medicine develops candidate drugs for anti-aging and cancer treatment.
| Month | Monthly visits | MoM |
|---|---|---|
| 2026-06 | 62.0K | — |
| 2026-07 | 63.7K | +2.7% |
| 2026-08 | 49.0K | -23.1% |
| 2026-09 | 64.7K | +32.2% |
| 2026-10 | 47.5K | -26.7% |
An AI recruiting platform unifying hiring workflows, talent relationships, and analytics.
+ CompareA platform connecting specialists with model research, training, and evaluation projects
+ CompareA conversational hiring agent that moves candidates from application through onboarding
+ CompareA talent-intelligence platform using agents to support hiring, development, and workforce deployment
+ CompareA clinician platform combining communication, telehealth, and AI-assisted documentation
+ CompareAn AI research and search platform built for professional investors
+ CompareAccording to AlphaMoat, Insilico Medicine (insilico.com) received 47,472 visits (about 47.5K) in October 2026 (-26.7% month over month), ranking #5,049 of 17,609 AI websites with traffic data, and #603 in Industry Services.
In October 2026, Insilico Medicine’s largest markets by share of visits are United States 47.1%, Hong Kong 13.2%, India 7.9%.
In Industry Services, the other products with the most monthly visits are Ashby (28.4M), Mercor (14.2M), Paradox (11.4M), Eightfold AI (11.0M), Doximity (10.0M).
Data month: 2026-10 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.